EU Drug Repurposing Pilot Kicks Off
Industry Welcomes Project, With Caveats
Executive Summary
A new European initiative will offer scientific advice, fee waivers and other support to not-for-profit and academic sponsors to help them find new uses for existing medicines and hook up with commercial companies to seek marketing authorization.
You may also be interested in...
New €23m EU Research Consortium To Accelerate Repurposing
REMEDi4ALL is the latest in a series of European initiatives to develop and centralize drug repurposing R&D. The group will identify, test and validate new indications for existing medicines on top of shaping policies favorable to repurposing.
UK Set To Launch Drug Repurposing Project
Licensing new uses of existing medicines has several benefits over off-label use, such as offering assurances that the indication is evidence based and subject to an ongoing safety monitoring program, according to a new report.
UK Set To Launch Drug Repurposing Project
Licensing new uses of existing medicines has several benefits over off-label use, such as offering assurances that the indication is evidence based and subject to an ongoing safety monitoring program, according to a new report.